I was contacted by a writer from the Wall Street Journal. He’s doing a piece on people with Hep C who have chosen to forgo the current treatment options for a few of the newer treatments coming available like
telaprevir and boceprivir, if and when they come available.

He asked me to put a request out to my readers to see if anyone would share their own perspective on why they made their decision to wait. Please contact him at the following address…

jonathan.rockoff (at) wsj (dot) com

I’m very sure he will use the utmost descretion in keeping your personal information private. And I thank you for helping others understand more about other treatment options.